From: Expression of ADAMs and Their Inhibitors in Sputum from Patients with Asthma
Patients with asthma | Control subjects | |
---|---|---|
n | 21 | 17 |
Mean age, years | 34 (20–67) | 29 (23–40) |
Sex, M/F | 16/5 | 7/10 |
FEV1, % predicted | 88 (36–123) | 92 (82–114) |
FEV1, mL | 3354 (1164–4920) | 3670 (2430–4130) |
PC20M, mg/mL | 0.80 (0.3–6.2) | ND |
Atopy, n | 18/21 | 0/17 |
Therapy | 21 NT | 17 NT |